Continuing Questions About Esketamine 5 Years After Approval: Response to Ahmed et al.
Am J Psychiatry September 1, 2026
Continuing Questions About Esketamine 5 Years After Approval: Response to Ahmed et al.
Am J Psychiatry
ISSN 0002-953x; 1535-7228;
16 papers in the library · 2,890 citations · publishing 1961-2026
Papers
Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions.
Am J Psychiatry September 1, 2026
Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions.
Prevalence and Correlates of Past-Year Psilocybin Use in the United States.
Am J Psychiatry April 22, 2026 Kevin H. Yang, Avery Eun, Joseph J Palamar
Prevalence and Correlates of Past-Year Psilocybin Use in the United States.
20 Years of Aberrant Salience in Psychosis: What Have We Learned?
Am J Psychiatry March 26, 2025 Philip R. Corlett, Kurt M. Fraser 9 citations
" captured the attention of clinicians and cognitive and behavioral neuroscientists. It has become the de facto way of talking about delusion formation in labs and clinics. Here, evidence for this theory is critically evaluated in consideration of evolving data since its publication. A particular focus is placed on its specific predictions regarding the neural and behavioral loci of dopamine...
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.
Am J Psychiatry 2025 Kelley C. O’donnell, Jim Grigsby, Charles S. Grob 9 citations
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.
Am J Psychiatry 2025 Aaron Wolfgang, Vetisha L. McClair, Paula P. Schnurr et al. 6 citations
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.
Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.
Am J Psychiatry 2024 Kelley C. O’donnell, Brian T Anderson, Frederick S. Barrett et al. 31 citations
Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary.
Am J Psychiatry 2024 Michael Alpert, Kelley C. O’donnell, Casey Paleos et al. 22 citations
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary.
Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.
Am J Psychiatry July 1, 2011
Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.
Persistent psychosis associated with salvia divinorum use.
Am J Psychiatry July 1, 2009
Persistent psychosis associated with salvia divinorum use.
Imagery rehearsal therapy for acute posttraumatic nightmares among combat soldiers in Iraq.
Am J Psychiatry April 1, 2007
Imagery rehearsal therapy for acute posttraumatic nightmares among combat soldiers in Iraq.
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.
Am J Psychiatry 2003 Shitij Kapur 2,813 citations
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.
Potential interaction of LSD and fluoxetine.
Am J Psychiatry June 1, 1992
Potential interaction of LSD and fluoxetine.
Out-of-body experiences and migraine.
Am J Psychiatry October 1, 1982
Out-of-body experiences and migraine.
Charismatic religious experience and large-group psychology.
Am J Psychiatry December 1, 1980
Charismatic religious experience and large-group psychology.
Spirit possession in Haiti.
Am J Psychiatry August 1, 1961
Spirit possession in Haiti.